Silke Stoerzer-Duerr

Otfried Mueller Str. 10
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation.

Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: March 02, 2022

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.

Journal: Haematologica

Published: July 22, 2020

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.

Journal: Cancers

Published: March 24, 2020

Inhibition of effector B cells by ibrutinib in systemic sclerosis.

Inhibition of effector B cells by ibrutinib in systemic sclerosis.

Journal: Arthritis research & therapy

Published: January 20, 2020

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner.

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner.

Journal: Frontiers in immunology

Published: March 06, 2019

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.

Journal: Arthritis research & therapy

Published: October 30, 2018

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.

Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9.

Journal: Oncogene

Published: October 04, 2018

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia.

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia.

Journal: Frontiers in immunology

Published: April 06, 2018

Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation.

Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation.

Journal: Clinical transplantation

Published: April 25, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026